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Wegener's granulomatosis frequently involves the subgiottis and trachea, 
often leading to compromise of the upper airway. Moreover, the stenotic 
segments may persist or progress despite control of the disease elsewhere 
in the body. In this report, we describe the cases of five patients with 
Wegener's granulomatosis who, in addition to nasal, sinus, pulmonary and 
renal involvement, had symptomatic subglottic or tracheal stenosis. Biopsy 
specimens from involved sites in the subglottis and trachea were often not 
diagnostic, and the diagnosis was later confirmed by a positive antineutro- 
phil cytoplasm antibody titer. All patients had clinical remission on 
standard therapeutic regimens with prednisone and cyclophosphamide but 
continued to have symptoms of extrathoracic airway obstruction. Three of 
the five patients underwent primary thyrotracheal anastomosis while their 
disease was in clinical remission, without postoperative compromise of 
anastomotic integrity or wound healing despite concurrent use of pred- 
nisone and cyclophosphamide. There has been no evidence of local disease 
recurrence during follow-up periods ranging from 3 months to 14 years. We 
conclude that surgical intervention is a viable treatment option for patients 
who have symptomatic stenotic segments of the subglottis and trachea as a 
result of Wegener's granulomatosis in clinical remission. (J Thorac Car- 
diovasc Surg 1996;111:961-6) 
F riedrich Wegener first described what he called "rhinogenic granulomatosis" as a unique clinical 
entity in 1936.1 By 1954, formalized iagnostic ri- 
teria for Wegener's granulomatosis (WG) were 
established; these included involvement of the 
respiratory tract with necrotizing granulomatous 
inflammation coincident with focal necrotizing lo- 
merulonephritis and varying degrees of generalized 
vasculitis. 2 Subsequently, the concept of limited WG 
became well accepted as different authors docu- 
mented its characteristic morphologic and his- 
topathologic haracteristics in isolated anatomic 
sites. 3-7 To date, a number of case reports and series 
have documented WG involving the subglottis and 
From the Departments of Medicine, Division of Respiratory 
Diseases, a and Surgery, Division of Thoracic Surgery, b Uni- 
versity of Toronto, and The Toronto Hospital, Toronto 
General Division, Toronto, Ontario, Canada. 
Received for publication Feb. 23, 1995. 
Accepted for publication June 14, 1995. 
Address for reprints: G. Downey, MD, FRCP(C), E10-212, The 
Toronto Hospital, General Division, 200 Elizabeth St., To- 
ronto, Ontario M5G 2C4, Canada. 
Copyright © 1996 by Mosby-Year Book, Inc. 
0022-5223/96 $5.00 + 0 12/1/67041 
proximal trachea. 8-1° This is not a rare manifestation 
of WG; in a longitudinal study of 158 patients with 
WG, tracheal stenosis was observed to develop 
sometime during the course of the disease in 16%. 11 
In general, this limited form of disease responds 
to treatment with corticosteroids and cytotoxic 
agents.12, 13 Recently, however, we encountered sev- 
eral patients in whom symptomatic upper airway 
obstruction persisted or progressed espite control 
of the disease elsewhere. 
The feasibility and outcome of reconstructive 
surgery in these patients have not been well docu- 
mented. There has been a pervasive pessimism in 
the literature regarding the role of surgery in the 
treatment of WG of the subglottis and trachea. 
McDonald and colleagues 12 stated that reconstruc- 
tive surgery was not viable in patients with WG 
because they believed that concurrent use of immu- 
nosuppressive agents would interfere with adequate 
wound healing. Additionally, they believed that 
these interventions were impractical because of the 
possibility that local disease reactivation might lead 
to disruption of the anastomotic site. These reser- 
vations were reiterated by Hoare and colleagues, 14
who used laser vaporization to clear indolent sub- 
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glottic stenoses but considered that extensive laryn- 
geal reconstructive procedures would invariably fail 
because of disease recurrence. 
In this report, we describe a series of five cases of 
subglottic stenosis related to WG. Three of the 
patients in this series have undergone successful 
resection and reconstruction of their tracheal steno- 
sis during disease remission on a regimen of immu- 
nosuppressive therapy. We propose that surgical 
intervention is a viable option in selected patients 
whose disease has been initially controlled with 
medical therapy. 
Case reports 
CASE 1. A 36-year-old man was seen in 1984 with 
sinusitis, episcleritis, pulmonary infiltrates, polyarthritis, 
mononeuritis multiplex, and significant constitutional 
symptoms. WG was diagnosed by means of an open-lung 
biopsy. Treatment with pulsed methylprednisolone and 
cyclophosphamide was initiated, with good clinical re- 
sponse. Clinical remission was eventually achieved in 
1992, and steroid therapy was tapered. In July 1993, the 
patient had increasing hoarseness, dyspnea, decline in 
exercise tolerance, and stridor. Results of tests for an- 
tineutrophil cytoplasm antibody (ANCA) were positive, 
and gallium scan showed increased uptake in both sinuses, 
the upper airway, and lung fields. Spirometry showed an 
extrathoracic airway obstruction, and computed tomo- 
graphic scan of the trachea confirmed a 3 cm subglottic 
stenosis with an intact distal tracheobronchial tree. Ther- 
apy was initiated with methotrexate because of concerns 
about persistently ow leukocyte count after cyclophosph- 
amide therapy. The patient continued to have symptoms, 
and rigid bronchoscopy with dilation was undertaken in 
March 1994. At the time of this procedure, active upper 
airway disease was noted, as evidenced by septal perfora- 
tion and nasopharyngeal crusts. Biopsy samples from the 
subglottic and nasal areas showed nonspecific hronic 
inflammation. Tests for circulating ANCA (C-ANCA) 
and antiproteinase 3 remained positive. Therapy with 
prednisone and cyclophosphamide was initiated to 
achieve clinical remission before attempted tracheal re- 
construction. This patient continues to have clinical re- 
mission and is awaiting clinical reevaluation for consider- 
ation for surgical repair. 
CASE 2. A 48-year-old woman was initially seen in 1979 
with sinusitis, pulmonary infiltrates, and renal failure. WG 
was confirmed by means of an open-lung biopsy. The 
patient subsequently had dyspnea nd stridor, and a 2 cm 
tracheal stenosis 1 cm below the vocal cords was docu- 
mented by computed tomographic scan. The patient un- 
derwent rigid bronchoscopy with dilation and biopsy. 
Pathologic examination showed nonspecific granulation 
tissue with focal squamous metaplasia. Therapy with 
prednisone and cyclophosphamide was initiated, and the 
disease remitted. In July 1980, the patient underwent 
elective resection of the stenosis with thyrotracheal nas- 
tomosis. A Jackson tracheostomy was placed below the 
region of the anastomosis because of its close proximity to 
the cords. Before operation, the patient was receiving 20 
mg prednisone very 2 days and 125 mg cyclophospha- 
mide daily. The patient received perioperative steroid 
coverage, and after operation prednisone was restarted at 
a dosage of 10 mg daily. Cyclophosphamide was restarted 
on the third postoperative day at a dose of 125 mg daily. 
Four weeks after the procedure, the Jackson tube was 
removed and the tracheostomy stoma was allowed to 
close. The patient remained on a regimen of prednisone 
and cyclophosphamide for an additional 2years, at which 
time her disease remitted and the medications were 
tapered. During the past 14 years, since the time of 
operation, there has been no recurrence of WG, and the 
anastomosis has remained intact without recurrent steno- 
sis. 
CASE 3. A 29-year-old man was seen in 1983 with 
subglottic stenosis. The patient first came to medical 
attention at the age of 10 years with arthralgia, abdominal 
pain, vasculitic skin rash, and renal failure. Findings in 
several renal biopsy samples were not specific enough for 
diagnosis. A tentative diagnosis of Henoch-Sch6nlein 
purpura was made at that time. At the age of 17 years, the 
patient required regular dialysis, and he underwent an 
initial unsuccessful cadaveric renal transplant followed by 
a successful renal transplant from a living relative. He 
received immunosuppression with prednisone and cyclo- 
sporine A. In 1983, marked stridor developed, with severe 
nasal and laryngeal inflammation. A biopsy sample of 
inflamed oral mucosa demonstrated granulomatous in- 
flammation and vasculitic changes consistent with WG. 
Cyclophosphamide induced clinical remission, and cyclo- 
sporine A was discontinued. Prednisone was added to his 
regimen several years later, when the cyclophosphamide 
dose was tapered. In June 1993, symptoms of stridor on 
vigorous exertion developed, and at another medical 
center the patient underwent elective resection of a 2.5 cm 
subglottic stenosis with primary anastomosis. At the time 
of operation, he was taking 20 mg prednisone very 2 days 
and 50 mg cyclophosphamide aily. A violent vomiting 
episode 5 days after operation resulted in incomplete 
dehiscence of the primary anastomosis and subcutaneous 
emphysema. The latter resolved after insertion of a Pen- 
rose drain. In August 1993, the patient had recurrent 
dyspnea and stridor necessitating tracheostomy. Com- 
puted tomographic scan demonstrated a 2 cm subglottic 
stenosis close to the anastomotic site. Bronchoscopy 
showed evidence of active WG at the carina and main 
stem bronchi. Therapy with high-dose prednisone and 
cyclophosphamide was initiated. Three months later, the 
patient's disease remitted and he underwent stenotic 
resection with primary thyrotracheal anastomosis. A
Montgomery T-tube was left in place as a stent. At the 
time of operation, the patient was receiving 15 mg pred- 
nisone every 2 days. He received perioperative steroid 
coverage, but prednisone was withheld until postoperative 
day 10. Cyclophosphamide was reinstituted on third post- 
operative day 3. Currently, this patient's disease remains 
in remission and he continues on his immunosuppressive 
regimen. His anastomosis remains intact 18 months after 
operation, without evidence of recurrent stenosis. 
CASE 4. A 39-year-old woman was seen in 1991 with 
frontal headache, earache, swollen gums, and constitu- 
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tional symptoms. A transnasal biopsy sample showed 
granulomatous inflammation consistent with WG. The 
patient was started on a regimen of prednisone, cyclo- 
phosphamide, and trimethoprim-sulfamethoxasole, with 
good clinical response. Nine months later, she had exer- 
tional dyspnea, decline in exercise tolerance, and occa- 
sional inspiratory stridor. She was admitted to our insti- 
tution, and flexible bronchoscopy showed an inflammatory 
web with tracheal narrowing involving 2 cm of subglottic 
trachea. There was also evidence of distal disease of the 
main stem bronchi and lobar orifices. Results of C-ANCA 
testing were positive. Rigid bronchoscopy with dilation of 
the stricture was performed. Biopsy samples from the 
affected sites showed nonspecific hronic inflammation. 
Cyclophosphamide was discontinued because of bone 
marrow suppression; this therapy was replaced with meth- 
otrexate and azathioprine. Methotrexate was subse- 
quently discontinued, and the patient's disease has re- 
mained in remission. There has been no recurrence of 
upper airway obstruction i  22 months of follow-up. 
CASE 5. A 29-year-old woman was initially seen in 1990 
with acute renal failure. Subsequent renal biopsy confirmed 
WG. Results of C-ANCA testing were positive at that time. 
The patient was maintained on a regimen of prednisone and 
cyclophosphamide after acute treatment with plasmaphere- 
sis and remained well until April 1990, when she had acute 
upper airway obstruction. Bronchoscopy demonstrated sub- 
glottic stenosis with a 4 mm residual orifice. Concurrent 
nasal involvement was present at that time. Despite three 
laser esections and T-tube placement, the patient continued 
to require a tracheostomy because of residual stenosis. In 
September 1994, she was referred to our center for further 
management. Another bronchoscopy and laryngoscopy 
demonstrated ananterior subglottic web with normal poste- 
rior glottis and a circumferential tracheal stenosis 1.2 cm in 
length beginning 1.8 cm below the vocal cords. These 
findings were confirmed by computed tomographic s an of 
the trachea. In anticipation of operation, the patient's main- 
tenance dose of 50 mg prednisone was gradually tapered to 
5 mg on alternating days. She continued to take 75 mg 
cyclophosphamide aily. In November 1994, she underwent 
resection of the first, second, and third tracheal rings, partial 
cricoid resection, and laryngofissure and laryngoplasty for 
posterior stenosis. A T-tube was introduced at that time. 
Pathologic examination of the resected segment demon- 
strated nonspecific hronic inflammation. The patient re- 
ceived perioperative steroid coverage and resumed taking 5 
mg prednisone on alternating days on the second postoper- 
ative day. Cyclophosphamide ata dosage of 75 mg per day 
was continued until the day of operation and was resumed 
on the second postoperative day. The patient's disease 
remains in clinical remission and she has an intact primary 
anastomosis 6 months after operation. 
Operative technique 
In all five cases reviewed in this report, the 
proximal margin of the pathologic area involved the 
soft tissues of the subglottic airway in circumferen- 
tial fashion. Anatomically, the subglottic airway 
extends from the inferior border of the vocal folds to 
the lower border of the cricoid cartilage. The distal 
extent of the pathologic process extends into the 
upper cervical trachea for a variable distance. The 
longest stenosed segment observed in these five 
cases was 3 cm. 
In the three patients whose disease was managed 
by resection and reconstruction with primary anas- 
tomosis, a circumferential segment of the upper 
airway was removed. This segment included a part 
of the cricoid cartilage. This technique was origi- 
nally described by one of us in 1975,15 and a detailed 
description of this technique was recently published 
by Maddaus and PearsonJ 6 Figs. 1 through 3 illus- 
trate diagrammatically the technique of resection. 
Discussion 
Stenosis of the subglottis and proximal trachea is 
an important complication of WG. Although only 
2% of patients are initially seen with this manifes- 
tation, 16% of patients have this complication at 
some time during the course of their disease. 11 
A series of 17 patients with subglottic or tracheal 
involvement was studied at the Mayo Clinic between 
1964 and 1982.12 In all affected patients, there was 
evidence of another site of disease involvement at 
presentation, and all had evidence of concurrent 
nasal involvement. Fourteen of these patients had 
symptoms of hoarseness and progressive stridor. 
Tissue histologic examination often yielded only 
nondiagnostic hanges of chronic inflammation. 
These authors reported a uniformly excellent re- 
sponse to conventional therapy with cyclophospha- 
mide and corticosteroids. 
Our patients hared many characteristics with this 
group. All had nasal involvement at presentation 
with subglottic stenosis and sparing of the distal 
trachea. Other organ systems were less frequently 
involved (Table I). Biopsy specimens from areas of 
active tracheal involvement frequently did not show 
diagnostic hanges, showing evidence only of non- 
specific inflammation. In each of our cases, clinical 
remission was achieved with a standard protocol of 
cyclophosphamide and prednisone. 11The patients 
in our series, however, had persistent and symptom- 
atic tracheal stenosis despite previous successful 
medical therapy, laser treatment, and dilation. One 
patient continued to require a tracheostomy despite 
all of these different reatment modalities. 
The diagnosis of subglottic stenosis as a result of 
WG is often difficult. Evidence of vasculitic hanges, 
giant cells, and granulomata are frequently absent in 
specimens obtained from the upper respiratory 
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Fig. 1. Diagram illustrating beginning of resection of 
anterior cricoid arch. The arch has been freed subperi- 
chondrally, and illustration shows cartilage being removed 
with a rongeur. 
tract. 13 Other causes of stenosis, including carci- 
noma, tuberculosis, yphilis, and lymphoma, need to 
be excluded because their optimal treatments differ 
considerably, and any delay contributes to increased 
morbidity and mortality. Several authors have de- 
scribed the usefulness of ANCA titers in establish- 
ing the diagnosis of WG in patients with tracheal 
stenosis and nonspecific hanges of chronic inflam- 
mation found in a biopsy specimen. TM 17, is Hoare 
and colleagues j4 observed that all four patients with 
WG and subglottic stenosis in their series had a 
detectable ANCA titer. They advocated the routine 
use of ANCA assay for patients with subglottic 
stenosis of uncertain origin. TM In three of our five 
cases, C-ANCA assay was used to establish the 
presence of active WG (Table I). In the other two 
cases, a tissue diagnosis was made and ANCA 
testing was not carried out. Our observations further 
underscore the clinical usefulness of ANCA testing 
in the setting of recurrent subglottic stenosis with 
nonspecific histologic features. 
In our series of five patients, three successfully 
underwent racheal reconstruction while receiving 
immunosuppressive th rapy. It is important to note 
that none of these patients had significant postop- 
erative morbidity and none has died. Patients 2, 3, 
and 5 all underwent primary thyrotracheal nasto- 
moses while their disease was in remission on a 
regimen of prednisone and cyclophosphamide. All
received perioperative steroid coverage and cyclo- 
i. 
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Fig. 2. Diagram illustrating appearance after division 
of the cervical trachea distal to pathologic area. Distal 
tracheal stump is intubated, and pathologic area is seen 
lying within the cricoid cartilage. Entire anterior arch 
has been removed, leaving only a posterior shell of 
cricoid cartilage (top). The upper margin of the ste- 
nosed subglottic segment is divided at the level of the 
inferior border of thyroid cartilage (bottom). 
phosphamide was restarted 2 to 3 days after opera- 
tion. It is noteworthy that every effort was made to 
minimize the dose of corticosteroids given in the 
perioperative period. 
In summary, we have defined a group of patients 
who had persistent tracheal stenosis despite previ- 
ous therapeutic interventions. Patients in this sub- 
group should be offered resection and primary re- 
anastomosis as a definitive reconstructive procedure 
to obviate the need for tracheostomy and improve 
functional status and quality of life. Our patients 
had uniformly excellent clinical outcomes, and thus 
far there has been no evidence of disease recurrence 
at the anastomotic site or in any other organ sys- 
tems. We conclude that primary thyrotracheal nas- 
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Fig. 3. A primary anastomosis i created between distal trachea and subglottic airway at the level of the 
thyroid cartilage, identified in the left panel of the diagram. The technique of interrupted suture is shown 
in the right panel. As shown, the anastomosis lies at the level of the lower border of the thyroid cartilage, 
and the posterior part of the anastomosis lies anterior to the remaining posterior cricoid plate. 
Table I. Summary of patient characteristics 
Site of 
Age at stenosis 
Patient presentation and length Years after Other organ ANCA 
no. (yr) Sex of segment operation Pathology involvement titer 
1 36 F Subglottic, 3 cm NA 
2 33 F Subglottic, 2 cm 14 
3 29 M Subglottic, 2 cm 1 
4 39 F Subglottic, 2 cm NA 
5 21 F Subglottic, 1.2 cm 0.17 
Nonspecific inflammation Sinuses, nasal, lung + 
Nonspecific inflammation Sinuses, nasal, lung, renal Not done 
Granulomatous Oral, nasal Not done 
inflammation 
Granulomatous Oral, nasal + 
inflammation 
Nonspecific inflammation Nasal, renal + 
tomosis is a viable treatment option in patients with 
WG and symptomatic subglottic stenosis whose 
disease is in clinical remission on a regimen of 
appropriate immunosuppressive th rapy for WG. 
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